David R Janz1, Jonathan D Casey2, Matthew W Semler2, Derek W Russell3, James Dargin4, Derek J Vonderhaar5, Kevin M Dischert6, Jason R West7, Susan Stempek4, Joanne Wozniak4, Nicholas Caputo7, Brent E Heideman2, Aline N Zouk3, Swati Gulati3, William S Stigler3, Itay Bentov8, Aaron M Joffe8, Todd W Rice2. 1. Department of Medicine, Section of Pulmonary, Critical Care Medicine, and Allergy and Immunology, Louisiana State University School of Medicine New Orleans, New Orleans, LA, USA. Electronic address: djanz@lsuhsc.edu. 2. Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA. 3. Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, AL, USA. 4. Department of Medicine, Division of Pulmonary and Critical Care Medicine, Lahey Hospital and Medical Center, Burlington, MA, USA. 5. Section of Emergency Medicine, Louisiana State University School of Medicine New Orleans, New Orleans, LA, USA; Department of Pulmonary and Critical Care Medicine, Ochsner Health System New Orleans, New Orleans, LA USA. 6. Department of Medicine, Division of Pulmonary and Critical Care, University of Washington School of Medicine, Seattle, WA, USA. 7. Department of Emergency Medicine, Lincoln Medical Center, The Bronx, New York, NY, USA. 8. Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA, USA.
Abstract
BACKGROUND: Tracheal intubation is common in the care of critically ill adults and is frequently complicated by hypotension, cardiac arrest, or death. We aimed to evaluate administration of an intravenous fluid bolus to prevent cardiovascular collapse during intubation of critically ill adults. METHODS: We did a pragmatic, multicentre, unblinded, randomised trial in nine sites (eight ICUs and one emergency department) around the USA. Critically ill adults (≥18 years) undergoing tracheal intubation were randomly assigned (1:1, block sizes of 2, 4, and 6, stratified by study site) to either an intravenous infusion of 500 mL of crystalloid solution or no fluid bolus. The primary outcome, assessed in the intention-to-treat population, was cardiovascular collapse, defined as a new systolic blood pressure <65 mm Hg; new or increased vasopressor receipt between induction and 2 min after tracheal intubation; or cardiac arrest or death within 1 h of tracheal intubation. Adverse events were assessed in the as-treated population. This trial, which is now complete, is registered with ClinicalTrials.gov, number NCT03026777. FINDINGS: Patients were enrolled from Feb 6, 2017, to Jan 9, 2018, when the data and safety monitoring board stopped the trial on the basis of futility. By trial termination, 337 (63%) of 537 screened adults had been randomly assigned. Cardiovascular collapse occurred in 33 (20%) of 168 patients in the fluid bolus group compared with 31 (18%) of 169 patients in the no fluid bolus group (absolute difference 1·3% [95% CI -7·1% to 9·7%]; p=0·76). The individual components of the cardiovascular collapse composite outcome did not differ between groups (new systolic blood pressure <65 mm Hg 11 [7%] in the bolus group vs ten [6%] in the no-bolus group, new or increased vasopressor 32 [19%] vs 31 [18%], cardiac arrest within 1 h seven [4%] vs two [1%], death within 1 h of intubation two [1%] vs one [1%]). In-hospital mortality was not significantly different in the fluid bolus group (48 [29%]) compared with no fluid bolus (59 [35%]). INTERPRETATION: Administration of an intravenous fluid bolus did not decrease the overall incidence of cardiovascular collapse during tracheal intubation of critically ill adults compared with no fluid bolus in this trial. FUNDING: US National Institutes of Health.
BACKGROUND: Tracheal intubation is common in the care of critically ill adults and is frequently complicated by hypotension, cardiac arrest, or death. We aimed to evaluate administration of an intravenous fluid bolus to prevent cardiovascular collapse during intubation of critically ill adults. METHODS: We did a pragmatic, multicentre, unblinded, randomised trial in nine sites (eight ICUs and one emergency department) around the USA. Critically ill adults (≥18 years) undergoing tracheal intubation were randomly assigned (1:1, block sizes of 2, 4, and 6, stratified by study site) to either an intravenous infusion of 500 mL of crystalloid solution or no fluid bolus. The primary outcome, assessed in the intention-to-treat population, was cardiovascular collapse, defined as a new systolic blood pressure <65 mm Hg; new or increased vasopressor receipt between induction and 2 min after tracheal intubation; or cardiac arrest or death within 1 h of tracheal intubation. Adverse events were assessed in the as-treated population. This trial, which is now complete, is registered with ClinicalTrials.gov, number NCT03026777. FINDINGS: Patients were enrolled from Feb 6, 2017, to Jan 9, 2018, when the data and safety monitoring board stopped the trial on the basis of futility. By trial termination, 337 (63%) of 537 screened adults had been randomly assigned. Cardiovascular collapse occurred in 33 (20%) of 168 patients in the fluid bolus group compared with 31 (18%) of 169 patients in the no fluid bolus group (absolute difference 1·3% [95% CI -7·1% to 9·7%]; p=0·76). The individual components of the cardiovascular collapse composite outcome did not differ between groups (new systolic blood pressure <65 mm Hg 11 [7%] in the bolus group vs ten [6%] in the no-bolus group, new or increased vasopressor 32 [19%] vs 31 [18%], cardiac arrest within 1 h seven [4%] vs two [1%], death within 1 h of intubation two [1%] vs one [1%]). In-hospital mortality was not significantly different in the fluid bolus group (48 [29%]) compared with no fluid bolus (59 [35%]). INTERPRETATION: Administration of an intravenous fluid bolus did not decrease the overall incidence of cardiovascular collapse during tracheal intubation of critically ill adults compared with no fluid bolus in this trial. FUNDING: US National Institutes of Health.
Authors: Michelle Duggan; Conán L McCaul; Patrick J McNamara; Doreen Engelberts; Cameron Ackerley; Brian P Kavanagh Journal: Am J Respir Crit Care Med Date: 2003-03-27 Impact factor: 21.405
Authors: Ake Norberg; Robert G Hahn; Husong Li; Joel Olsson; Donald S Prough; Elisabet Børsheim; Scott Wolf; Regina K Minton; Christer H Svensén Journal: Anesthesiology Date: 2007-07 Impact factor: 7.892
Authors: Liam Byrne; Nchafatso G Obonyo; Sara D Diab; Kimble R Dunster; Margaret R Passmore; Ai-Ching Boon; Louise See Hoe; Sanne Pedersen; Mohd Hashairi Fauzi; Leticia Pretti Pimenta; Frank Van Haren; Christopher M Anstey; Louise Cullen; John-Paul Tung; Kiran Shekar; Kathryn Maitland; John F Fraser Journal: Am J Respir Crit Care Med Date: 2018-10-15 Impact factor: 30.528
Authors: Stephen J Halliday; Jonathan D Casey; Todd W Rice; Matthew W Semler; David R Janz; Derek W Russell; James Dargin; Derek J Vonderhaar; Jason R West; Matthew M Churpek Journal: Ann Am Thorac Soc Date: 2020-08
Authors: Gerald Matchett; Omaira Azizad; Brian J Bravenec; Brian G Farrell; Dawood Nasir Journal: Intensive Care Med Date: 2022-03-31 Impact factor: 41.787
Authors: Gerald Matchett; Irina Gasanova; Christina A Riccio; Dawood Nasir; Mary C Sunna; Brian J Bravenec; Omaira Azizad; Brian Farrell; Abu Minhajuddin; Jesse W Stewart; Lawrence W Liang; Tiffany Sun Moon; Pamela E Fox; Callie G Ebeling; Miakka N Smith; Devin Trousdale; Babatunde O Ogunnaike Journal: Intensive Care Med Date: 2021-12-14 Impact factor: 41.787
Authors: Vincenzo Russotto; Sheila Nainan Myatra; John G Laffey; Elena Tassistro; Laura Antolini; Philippe Bauer; Jean Baptiste Lascarrou; Konstanty Szuldrzynski; Luigi Camporota; Paolo Pelosi; Massimiliano Sorbello; Andy Higgs; Robert Greif; Christian Putensen; Christina Agvald-Öhman; Athanasios Chalkias; Kristaps Bokums; David Brewster; Emanuela Rossi; Roberto Fumagalli; Antonio Pesenti; Giuseppe Foti; Giacomo Bellani Journal: JAMA Date: 2021-03-23 Impact factor: 56.272
Authors: Derek W Russell; Jonathan D Casey; Matthew W Semler; David Janz; Kevin W Gibbs; James M Dargin; Derek J Vonderhaar; A M Joffe; Shekhar Ghamande; Akram Khan; Simanta Dutta; Janna S Landsperger; Sarah W Robison; Itay Bentov; Joanne M Wozniak; Susan Stempek; Heath D White; Olivia F Krol; Matthew E Prekker; Brian E Driver; Joseph M Brewer; Li Wang; Christopher John Lindsell; Wesley H Self; Todd W Rice Journal: BMJ Open Date: 2020-09-18 Impact factor: 2.692
Authors: Garrett S Pacheco; Nicholas B Hurst; Asad E Patanwala; Cameron Hypes; Jarrod M Mosier; John C Sakles Journal: West J Emerg Med Date: 2021-02-01
Authors: Bişar Ergün; Begüm Ergan; Mehmet Nuri Yakar; Murat Küçük; Murat Özçelik; Erdem Yaka; Ali Necati Gökmen Journal: Rev Bras Ter Intensiva Date: 2022 Jan-Mar